Apple Inc. (AAPL.US) AirPods Pro 2 receives approval from the FDA in the United States, becoming a "over-the-counter hearing aid".
The Food and Drug Administration (FDA) has approved the hearing aid software for Apple's AirPods Pro 2, allowing them to be used as "over-the-counter hearing aids" in the United States.
The Food and Drug Administration (FDA) has approved the hearing aid software for Apple Inc.'s (AAPL.US) AirPods Pro 2, allowing the AirPods Pro 2 to be used as "over-the-counter hearing aids".
It is reported that the software's functions are aimed at individuals aged 18 and above, or those with mild to moderate hearing impairments. At the 2024 Apple Inc. fall product launch event, Apple Inc. announced that the AirPods Pro 2 will introduce some new hearing health-related features, with the updates set to be released later this year.
The updates include a default-enabled hearing protection mode (providing passive noise cancellation in noisy environments), as well as a "clinical-grade" hearing aid mode where users will conduct a brief hearing test using AirPods and iPhone. If hearing loss is detected, a "personalized sound configuration" file will be created, allowing the AirPods Pro 2 to dynamically adjust sound according to the user's needs to help them hear external sounds more easily.
Apple Inc. stated that the personalized hearing configurations will be automatically applied to music, movies, games, phone calls, and other scenarios without the need to adjust any settings. These features can help individuals better engage in conversations and stay connected with people and their surroundings.
Related Articles

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.
GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025